Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2007
11/15/2007WO2007079753A3 Mutant deoxyadenosine kinase enzymes and their use
11/15/2007WO2007079183A3 Placental stem cell populations
11/15/2007WO2007063316A3 Method for identifying a modulator of a cell signalling
11/15/2007WO2007053827A3 Methods of islet separation during isolation
11/15/2007WO2007050798A3 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
11/15/2007WO2007035881A3 Apparatus and method for solid-phase kinetic analysis of templated elongation reactions
11/15/2007WO2007015848B1 Improved methods and compositions for increasing longevity and protein yield from a cell culture
11/15/2007WO2007002390A3 Compositions and methods for modulation of smn2 splicing
11/15/2007WO2006138275A3 Compositions and methods for treating and diagnosing cancer
11/15/2007WO2006078256A3 Polypeptides having xylanase activity and polynucleotides encoding same
11/15/2007WO2005120549A3 Local delivery of growth factors for stem cell transplantation
11/15/2007WO2005115454A3 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
11/15/2007WO2003018828A3 Molecular interaction sites of 16s ribosomal rna and methods of modulating the same
11/15/2007WO2003018754A3 Neural regeneration peptide and methods for their use in treatment of brain damage
11/15/2007WO2002099070A3 Compositions and methods for high-level, large-scale production of recombinant proteins
11/15/2007WO2002089857A3 Trans-viral vector mediated gene transfer to the retina
11/15/2007US20070266457 Root-Specific and Xylem Parenchyma-Specific Promoter
11/15/2007US20070266456 Methods and compositions for obtaining marker-free transgenic plants
11/15/2007US20070266454 comprising a plant transformation vector comprising a nucleotide sequence that encodes a DRO3 polypeptide; genetic engineering
11/15/2007US20070266452 screening agent for ability to modulate energy expenditure by administering agent to transgenic mouse whose genome comprises homozygous disruption of endogenous KSR-2 gene, where no KSR-2 protein is expressed and said mouse exhibits a phenotype comprising increased obesity and reduced energy expenditure
11/15/2007US20070266448 Method for the production of antibodies
11/15/2007US20070265558 Stem cells derived from bone marrow for tissue regeneration
11/15/2007US20070265333 For treatment of melanoma, colon cancer, and/or breast cancer
11/15/2007US20070265316 2-(2-Chloro-benzoylamino)-4,5,6,7-tetrahydro-benzo thiophene-3-carboxylic acid amide; increasing activity of mutant-cystic fibrosis transmembrane conductance regulator protein in a cell; increasing halide ion permeability of a cell producing a Delta F508-CFTR protein
11/15/2007US20070265246 Treatment of an Intestinal Adenoma and/or Adenocarcinoma by Inhibition of Notch Pathway Activation
11/15/2007US20070265217 Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
11/15/2007US20070265205 nucleotide sequence that code an insecticidal protein for resistance against coleopteran pest the corn rootworm
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265196 Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
11/15/2007US20070265189 Insulin and igf-1 receptor agonists and antagonists
11/15/2007US20070264714 Growth differentiation factor-9 regulatory sequences and uses therefor
11/15/2007US20070264713 Propagating fibrblast progenitor cells on microcarriers in vessels; tissue engineering
11/15/2007US20070264712 Expansion and differentiation of neural stem cells under low oxygen conditions
11/15/2007US20070264711 Human pellino polypeptides
11/15/2007US20070264710 Process for Purifying Human Thrombopoietin with High Content of Sialic Acid
11/15/2007US20070264709 pluripotent cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, beta 3-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2
11/15/2007US20070264690 Nucleic acids encoding lettuce big-vein viral proteins and utilization thereof
11/15/2007US20070264689 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
11/15/2007US20070264688 Synthetic genomes
11/15/2007US20070264687 Recombinant triplex scaffold-based polypeptides
11/15/2007US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007US20070264685 Polynucleotides encoding cytokine receptor
11/15/2007US20070264682 Cell culture model and applications thereof
11/15/2007US20070264681 Determining the transition between different phases of the cell cycle in mammalian cells; non-destructive
11/15/2007US20070264675 Microfluidic device for cell separation and uses thereof
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264408 testing the DNA in its milk of the bovine animal; for identifying a physical trait of an animal, determine the cow has the absence of the beta -casein A1 protein or the percentage of saturated fats
11/15/2007US20070264311 Cysteine Protease from Ginger (Zingiber) as a Food Improver and Anti-Inflammatory
11/15/2007US20070264281 Vaccination Vectors Derived From Lymphotropic Human Herpes Viruses 6 and 7
11/15/2007US20070264278 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
11/15/2007US20070264277 Compositions and Methods of Use for Mgd-Csf in Disease Treatment
11/15/2007US20070264275 Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy
11/15/2007US20070264274 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
11/15/2007US20070264269 Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
11/15/2007US20070264268 screening for somatomedin receptor modulators comprising contacting a mannoside polypeptide or nucleic acid bioassay with a test agent and detecting the test agents biased activity of the bioassay; drug screening; animal models
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264258 Sialoadhesin factor-2 antibodies
11/15/2007US20070264255 Antibodies to TGF-beta
11/15/2007US20070264254 Cardiac muscle function and manipulation
11/15/2007US20070264253 Human Anti-Epidermal Growth Factor Receptor Antibody
11/15/2007US20070264245 Compositions and minimally invasive methods for treating incomplete tissue repair
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264243 Reversibly immortalized hepatocytes and methods of use
11/15/2007US20070264242 modified non-small cell lung cancer (NSCLC) cells or small cell lung cancer (SCLC) cells; Transforming Growth Factors- beta s (TGF beta s); Gene therapy for antagonizing a transforming growth factors-beta; anticarcinogenic agents
11/15/2007US20070264240 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
11/15/2007US20070264239 Isolation of pericytes
11/15/2007US20070264236 Novel Therapeutic Fusion Proteins
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264232 Cell populations which co-express CD49c and CD90
11/15/2007US20070264231 Tumor-Homing Cells Engineered to Produce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) by Adenoviral-Mediated Gene Transfer
11/15/2007CA2652247A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007CA2651723A1 A novel group of esterases for the enantioselective production of fine and speciality chemicals
11/15/2007CA2651331A1 Monocyte-derived stem cells
11/15/2007CA2651326A1 Pancreatic islet-like cells
11/15/2007CA2651137A1 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
11/15/2007CA2651117A1 Method for producing stable mammalian cell lines producing high levels of recombinant proteins
11/15/2007CA2650861A1 Improved gene silencing methods
11/15/2007CA2650561A1 Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2638785A1 Anti-ephb4 antibodies and methods using same
11/14/2007EP1854892A1 Modified viral surface proteins wich bind to cells of tumor vasculature
11/14/2007EP1854891A1 New neomycin phosphotransferase genes and method for selecting highly productive recombining cells
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854881A1 METHODS OF IDENTIFYING PURKINJE CELLS USING THE Corl2 GENE AS A TARGET
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854876A2 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
11/14/2007EP1854875A1 Thermostable dna polymerase of the archaeal ampullavirus abv and its applications
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1853698A1 Methods for embryonic stem cell culture
11/14/2007EP1853629A2 Human ring specific bnp antibodies
11/14/2007EP1853301A2 Method and composition for repairing heart tissue
11/14/2007EP1853282A2 Method and composition for repairing epithelial and other cells and tissue
11/14/2007EP1853244A2 Method for the treatment of retinopathy of prematurity and related retinopathic diseases
11/14/2007EP1853110A2 Method of providing readily available cellular material derived from peripheral blood and a composition thereof
11/14/2007EP1819810A4 Method for the preparation of a dermal papilla tissue having hair follicle inductive potency
1 ... 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 ... 1827